Front. Microbiol. Frontiers in Microbiology Front. Microbiol. 1664-302X Frontiers Media S.A. 10.3389/fmicb.2017.01842 Microbiology Methods Himar1 Transposon for Efficient Random Mutagenesis in Aggregatibacter actinomycetemcomitans Ding Qinfeng Tan Kai Soo * Faculty of Dentistry, National University of Singapore, Singapore, Singapore

Edited by: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China

Reviewed by: Pallab Ghosh, Harvard Medical School, United States; Fernando Aleman, Scripps Research Institute, United States

*Correspondence: Kai Soo Tan, denkst@nus.edu.sg

This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology

 26 09 2017 2017 8 1842 08 06 2017 08 09 2017 Copyright © 2017 Ding and Tan. 2017 Ding and Tan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Aggregatibacter actinomycetemcomitans is the primary etiological agent of aggressive periodontal disease. Identification of novel virulence factors at the genome-wide level is hindered by lack of efficient genetic tools to perform mutagenesis in this organism. The Himar1 mariner transposon is known to yield a random distribution of insertions in an organism’s genome with requirement for only a TA dinucleotide target and is independent of host-specific factors. However, the utility of this system in A. actinomycetemcomitans is unknown. In this study, we found that Himar1 transposon mutagenesis occurs at a high frequency (×10-4), and can be universally applied to wild-type A. actinomycetemcomitans strains of serotypes a, b, and c. The Himar1 transposon inserts were stably inherited in A. actinomycetemcomitans transconjugants in the absence of antibiotics. A library of 16,000 mutant colonies of A. actinomycetemcomitans was screened for reduced biofilm formation. Mutants with transposon inserts in genes encoding pilus, putative ion transporters, multidrug resistant proteins, transcription regulators and enzymes involved in the synthesis of extracellular polymeric substance, bacterial metabolism and stress response were discovered in this screen. Our results demonstrated the utility of the Himar1 mutagenesis system as a novel genetic tool for functional genomic analysis in A. actinomycetemcomitans.

 mutagenesis conjugation biofilm adherence DNA transposable elements periodontal disease R221-000-042-133 Ministry of Education - Singapore10.13039/501100001459 Introduction

Aggregatibacter actinomycetemcomitans, a gram-negative coccobacillus is strongly associated with localized aggressive periodontal disease which involves rapid loss of alveolar bone in adolescents (Slots et al., 1980; Zambon, 1985; Haubek et al., 2008). This organism is also implicated in non-oral infections such as endocarditis, septicemia, and osteomyelitis (Martin et al., 1967; Meyer and Fives-Taylor, 1998; van Winkelhoff and Slots, 1999). A. actinomycetemcomitans expresses numerous virulence factors including leukotoxin, collagenase, and cytolethal distending toxin which contribute to the destruction of periodontium (Shenker et al., 2004; Kachlany, 2010). Even though substantial progress has been made in understanding the virulence of A. actinomycetemcomitans, it remains a challenge to study the genetics of the organism’s colonization and persistence in the oral cavity, and identify novel virulence factors due to limited genetic tools available to manipulate A. actinomycetemcomitans.

Forward genetics is a powerful tool to identify novel genes critical for virulence. Tn916, Tn5, Tn10, and IS903 based gene delivery systems have been used to generate mutant libraries in A. actinomycetemcomitans which led to discovery of genes essential in virulence and survival of A. actinomycetemcomitans (Kolodrubetz and Kraig, 1994; Thomson et al., 1999; Kachlany et al., 2000a; Isaza et al., 2008; Nunes et al., 2016). However, these systems suffer from several drawbacks. The Tn916 and Tn5 systems have low efficiency of DNA transposition (≤10-7). Although this can be overcome by the use of Tn10 and IS903ϕkan systems which yield higher transposition efficiency, Tn10 system has preference for hotspots (Halling and Kleckner, 1982). The cryptic kan gene of the IS903ϕkan system is expressed only when inserted into an expressed gene in the appropriate reading frame to generate a gene fusion with kan gene (Thomson et al., 1999). Therefore, it remains challenging to obtain genome wide saturated mutagenesis of A. actinomycetemcomitans with the currently available mutagenesis systems. Furthermore, efficiency of these genetic manipulation systems varies considerably among serotypes of A. actinomycetemcomitans (Clewell and Gawron-Burke, 1986; Kolodrubetz and Kraig, 1994).

The mariner family of transposons, first identified in horn fly, is known to be widespread in nature. The Himar1 mariner transposon is one of the two known active mariner elements that have been successfully utilized for a number of oral and non-oral bacteria such as Pseudomonas aeruginosa (Withers et al., 2014), Porphyromonas gingivalis (Klein et al., 2012), and oral streptococci (Nilsson et al., 2014). A key feature that separates these elements from many other transposons is their independence from host-specific factors other than the presence of a TA dinucleotide target (Lampe et al., 1998). In addition, the Himar1 transposon system is known to yield a random distribution of insertions in genome (Nilsson et al., 2014; Withers et al., 2014). However, the usefulness of this mutagenesis system in A. actinomycetemcomitans has not been determined. In this study, we report the utility of the Himar1 transposon system to perform genome wide mutagenesis in A. actinomycetemcomitans of different serotypes. Since biofilm formation is critical for A. actinomycetemcomitans’ persistence in the oral cavity, in this work, we describe the genetic screen and present data that supports its use as an effective method for identifying novel genetic elements involved in the biofilm formation of A. actinomycetemcomitans.

 Materials and Methods Bacterial Strains and Culture Conditions

Aggregatibacter actinomycetemcomitans ATCC 700685 (strain HK1651, serotype b), ATCC 33384 (strain NCTC 9710, serotype c), ATCC 43717 (strain SUNYab 75, serotype a), ATCC 43719 (strain SUNYab 67, serotype c) were obtained from the American Type Culture Collection (Manassas). All A. actinomycetemcomitans strains used in this study were chloramphenicol and kanamycin sensitive. Bacteria were cultured in brain heart infusion (BHI) broth (Acumedia) and incubated at 37°C in an atmosphere supplemented with 5% CO2. E. coli 1354 (Barrett et al., 2008), a diaminopimelic acid (DAP) auxotroph, was cultured in LB broth (Acumedia) supplemented with 100 μg/mL DAP (Sigma) and incubated with aeration at 37°C.

 Transposon Mutagenesis

The Himar1 transposon delivery plasmid, pUTE664-oriT (Figure 1), was kindly provided by Mr. Yahua Chen from the National University of Singapore. pUTE664-oriT was transformed into E. coli 1354 by electroporation, and selected on LB agar supplemented with 100 μg/mL DAP (Sigma) and 20 μg/mL chloramphenicol. A library of A. actinomycetemcomitans transconjugants was generated as follows. Overnight cultures of A. actinomycetemcomitans and E. coli 1354pUTE664-oriT were diluted 1:10 in fresh BHI and LB broth supplemented with 100 μg/mL DAP and 20 μg/mL chloramphenicol, respectively, and grown for 6 h. Conjugation was performed by mixing A. actinomycetemcomitans (5 × 108 CFU) and E. coli 1354pUTE664-oriT (1 × 108 CFU) and resuspending in a final volume of 50 μL fresh BHI broth with DAP (100 μg/mL), and spreading onto a piece of cellulose nitrate paper (Sartorius) placed over the surface of a BHI agar plate. Conjugation was allowed to take place for 6 h at 37°C in an aerobic atmosphere with 5% CO2. Bacteria were washed off from the surface of the filter paper with 1 mL BHI broth, and 100 μL of the bacterial suspension was plated on BHI selective agar supplemented with 12.5 μg/mL kanamycin, and incubated at 37°C in an atmosphere with 5% CO2 for 48 h. The frequency of transposition was calculated as the number of mutants on selective agars (plasmid recipient) divided by the number of E. coli 1354pUTE664-oriT (plasmid donor).

Vector map of pUTE664-oriT. This plasmid contains a functional mariner inverted terminal repeat (ITR) with kanamycin (Km) resistance cassette, and a backbone vector including a hyperactive Himar1 transposase. ori, replication origin of plasmid in E. coli; oriT, transfer function; KmR, kanamycin resistant gene; CmR, chloramphenicol resistant gene.

 Characterization of <italic>A. actinomycetemcomitans</italic> Transposon Mutants

To determine if the Himar1-based transposon has integrated into the genome of A. actinomycetemcomitans, each isolated single colony of transposon mutants was picked and inoculated on BHI agar supplemented with either 12.5 μg/mL kanamycin or 20 μg/mL chloramphenicol in parallel. Following successful integration of transposon into the bacterial genome, the backbone of plasmid conferring resistance to chloramphenicol resistant gene will be lost. Therefore, being resistant to kanamycin and sensitive to chloramphenicol is an indication that the plasmid has integrated into the genome. The stability of the transposon inserts was determined through serial passaging of isolated mutants on BHI agar without antibiotics for seven passages. The presence of the Himar1 transposon cassette in the genome of these mutants was further validated by PCR. Genomic DNA was isolated from these mutants using the QIAamp DNA mini purification kit (Qiagen) according to the manufacturer’s protocol. PCR reaction consisted of 100 ng of genomic DNA, 0.5 μM each of forward and reverse primers targeting the kanamycin cassette, GoTaq Master Mix in a final volume of 20 μL. Sequences of primer used were HimarKm forward (5′-CCGGTATAAAGGGACCACCT) and reverse (5′- CAGGCTTGATCCCCAGTAAG). The PCR thermocycling consisted of an initial denaturation at 94°C for 3 min followed by 35 cycles of 94°C for 40 s, 59°C for 40 s, and 72°C for 30 s, and a final extension of 72°C for 10 min. The PCR products were analyzed on a 1.5% agarose gel.

 Southern Blot Analysis

Genomic DNA was digested with the restriction enzymes EcoRI (Promega) and BamHI (Promega). Following digestion, DNA fragments were purified by ethanol precipitation. Purified DNA fragments were electrophoresed on a 0.8% agarose gel (BioRad). DNA was transferred to a nitrocellulose membrane (BioRad) via capillary transfer for Southern hybridization which was carried out as described previously (Sambrook et al., 1989). A 600 bp fragment of the Himar1 transposon was amplified by PCR as described above using primers HimarKm forward and reverse. This DNA fragment was used as probe. Labeling and detection of the probe was carried out using the DIG high prime DNA labeling and detection kit (Roche) according to the manufacturer’s protocol.

 Identification of Transposon Insertion Site

To determine the site of Himar1 insertion, genomic DNA was isolated from the mutants using the QIAamp DNA mini purification kit (Qiagen) according to the manufacturer’s protocol. DNA sequences flanking the transposon were determined by inverse PCR and DNA sequencing. Bacterial genomic DNA was digested with Sau3AI (Promega) and self-ligated with T4 DNA ligase (Promega), and used as template for PCR. Inverse PCR was carried out using primers H2 (5′- CCAACCTTCAAATGATTCCC) and H3 (5′- GGTACTATATAAAAATAATATGCATTTAATACTAGCG), which hybridize to the end of the kanamycin resistance gene and are oriented outward. PCR reaction consisted of 2 μL of ligation mix, 0.5 μM each of H2 and H3 primers, GoTaq Master Mix (Promega), in a final volume of 50 μL. The thermal cycling protocol used was an initial denaturation of 94°C, 3 min for 1 cycle, followed by 35 cycles of 94°C for 30 s; 57°C for 30 s and 72°C for 2 min. The PCR product was purified using a PCR purification kit (Promega) and sequenced using primer H4 (5′-TATGCATTTAATACTAGCGACG). DNA sequences obtained were analyzed by BLASTN to determine the location of transposon insertion sites.

 Screening for Mutants Defective in Biofilm Formation

A library of A. actinomycetemcomitans ATCC 700685 transposon mutants were generated as described above. A. actinomycetemcomitans biofilms were cultured in 96-well flat bottom polystyrene plates (Thermo Fisher Scientific) and incubated at 37°C supplemented with 5% CO2 for 24 h. Crystal violet assay was carried out to quantify the amount of biofilm formed. Planktonic cells were removed and the biofilm was washed once with sterile PBS to remove residual planktonic cells. The biofilm was fixed with methanol for 10 min, after which methanol was removed and the wells allowed to air dry. Subsequently, biofilm was stained with 1% crystal violet (Sigma) for 10 min, and excess dye was removed by washing the well with distilled H2O. Bound crystal violet was dissolved using 33% acetic acid (Sigma), and absorbance read at optical density 580 nm. Presumptive biofilm deficient mutants obtained from the initial screen were retested in three independent trials. Each putative biofilm deficient mutant was inoculated into BHI broth and the optical density at 600 nm was determined following 24 h incubation at 37°C in an atmosphere with 5% CO2. Transposon insertion sites were determined only for selected mutants which were not defective in growth but deficient in biofilm formation compared to the wild-type strain.

 Results <italic>Himar1</italic> Transposon Mutagenesis in <italic>A. actinomycetemcomitans</italic>

We found that Himar1-based transposon mutagenesis can be successfully applied in four different A. actinomycetemcomitans strains, belonging to serotypes a, b, and c. The transposition frequencies for all the four bacterial strains did not vary significantly at ×10-4, indicating that high frequency of transposition was obtained. For each strain, randomly picked transconjugants (n = 31) were kanamycin resistant and chloramphenicol sensitive, demonstrating that the plasmid containing the mariner transposon was not capable of replicating in A. actinomycetemcomitans (Figure 2). The stability of transposon inserts was determined in A. actinomycetemcomitans ATCC 700685 (serotype b) which is the most commonly isolated serotype from patients with aggressive periodontitis (Zambon et al., 1983). The presence of the transposon inserts was determined in 31 randomly picked transconjugants by determining their ability to grow on kanamycin resistant agar after seven passages. At the 7th passage, bacterial cells would have undergone at least 150 generations since the doubling time of A. actinomycetemcomitans is about 3 h (Ding et al., 2016). This is consistent with previous reports that transposon insertions are stably inherited in A. actinomycetemcomitans (Kolodrubetz and Kraig, 1994; Thomson et al., 1999). We found that all 31 transconjugants were able to grow on agar plates with kanamycin following serial passaging (data not shown). PCR further showed the presence of the transposon cassette in the genome of these mutants (Figure 3). Mutants were randomly picked and Southern blot analysis was performed to confirm single transposon insertion. All 13 mutants analyzed showed single insertion in the genome (Figure 4).

Resistance of Aggregatibacter actinomycetemcomitans transconjugants. Random transconjugants (n = 31) were selected and inoculated on either BHI agar supplemented with kanamycin (A,C,E,G) or chloramphenicol (B,D,F,H). The resistance of A. actinomycetemcomitans ATCC 700685 (A,B), 33384 (C,D), 43717 (E,F), and 43719 (G,H) wild-type (indicated as WT), and transconjugants to kanamycin and chloramphenicol are shown.

Verification of the presence of Himar1 transposon cassette. Genomic DNA was extracted from 11 randomly picked A. actinomycetemcomitans transconjugants after seven serial passages. PCR was carried out using primers targeting the kanamycin resistance cassette. Lane M: 1 kb ladder (Promega); lane 1–11: randomly picked mutants with Himar1 transposon insertions; lane 12: pUTE664-oriT (positive control); lane 13: genomic DNA of A. actinomycetemcomitans ATCC 700685; lane 14: no template DNA (negative control).

Southern blot of Himar1 transposon insertions. Genomic DNAs were extracted from 13 random transconjugants. DNA was digested with EcoRI and BamHI. Digoxigenin-labeled DNA containing the insertion sequence was used as a probe. The sizes of DNA markers are shown on the left in kilobases. Lanes 1–13 consisted of digested DNA from random transconjugants.

 Isolation of <italic>A. actinomycetemcomitans</italic> Mutants with Deficiency in Biofilm Formation

Biofilm formation is one of the important mechanisms employed by A. actinomycetemcomitans to enhance their survival in the oral cavity. We employed the Himar1 transposon insertion library to identify mutants defective in biofilm formation in A. actinomycetemcomitans ATCC 700685. Approximately 16,000 transposon mutants were obtained from our library of mutants, which have been verified beforehand to be kanamycin resistant and chloramphenicol sensitive. These mutants were screened for defects in biofilm formation using a microtiter plate biofilm assay. About 40% of these mutants were found to be defective in growth. As a mutation conferring a growth defect would affect biofilm formation directly or indirectly, only mutants exhibiting growth similar to that of wild-type strain were further studied (Figures 5A,B). A total of 25 mutants were identified to be biofilm deficient with biofilm biomass significantly lower than wild-type strain. The location of the transposon insertion sites in these mutants were determined and are shown in Table 1. Among the 22 mutants with transposon insertions in genes with annotated functions, eight belonged to putative membrane proteins including ion transporters, efflux pumps and secretion systems. The other 10 biofilm defective mutants possessed disruption in genes encoding putative enzymes involved in the synthesis of extracellular polymeric substance (EPS), proteins involved in bacterial metabolism and oxidative stress response, while three mutants with disruptions in transcription regulators were identified (i.e., transcriptional regulator TyrR, and transcriptional regulator LysR) to be important for biofilm formation. A mutant with transposon insertion in the pilus gene flp-1 which has been previously reported to be essentially in adherence of A. actinomycetemcomitans was also identified in our screen.

The biofilm forming ability of A. actinomycetemcomitans transconjugants. (A) Culture density of biofilm deficient mutants following overnight incubation at 37°C in an atmosphere with 5% CO2. (B) Fold differences in biomass in biofilm deficient transconjugants. Mutants were picked and cultured in 96-well polystyrene plates for 24 h, and the biomass of mutants were determined by crystal violet assay. WT: wild-type strain A. actinomycetemcomitans 700685.

Transposon insertion sites in Aggregatibacter actinomycetemcomitans ATCC 700685 mutants with reduction in biomass.

Functional groups Mutant No. Gene locus∗ Putative function Reduction in biomass Previously described
Membrane proteins 33-22 CF65_00062 multidrug resistance protein 43.9% No
41-40 CF65_02975 integral membrane protein 51.5% No
43-31 CF65_02334 outer membrane protein P1 precursor 45.5% No
47-57 CF65_01344 magnesium transporter CorA 53.0% No
49-82 CF65_01341 multidrug efflux protein 56.8% No
59-2 CF65_02805 peptidase C39 56.8% No
53-76 CF65_02294 Na+/H+ anti-porter NhaC 45.5% No
113-2 CF65_02532 TonB-dependent receptor 49.4% No
Gene regulation 51-10 CF65_01698 transcriptional regulator 67.5% No
53-12 CF65_01579 transcriptional regulator, TyrR 59.2% No
113-6 CF65_01794 transcriptional regulator, LysR family 51.0% No
Metabolism 33-32 CF65_02251 biotin sulfoxide reductase 48.2% No
44-72 CF65_02933 sulfur acceptor protein CsdL 51.0% No
46-91 CF65_02631 UDP-phosphate galactose phosphotransferase 45.7% No
48-83 CF65_01934 histidine phosphatase 54.7% No
59-1 CF65_02382 glucuronate isomerase 53.9% No
64-5 CF65_02983 pyruvate formate-lyase 52.9% No
113-7 CF65_03351 tRNA-Lys 48.3% No
113-8 CF65_02683 electron transporter 43.3% No
116-78 CF65_03076 23S ribosomal RNA 53.2% No
120-15 CF65_00557 ATPase 48.1% No
Other functions 123-98 CF65_00867 Flp-1 55.1% Yes
34-14 CF65_02545 hypothetical protein 54.2% No
44-43 CF65_00379 hypothetical protein 54.3% No
110-1 CF65_01357 hypothetical protein 54.5% No
∗Obtained from NCBI. Discussion

We have demonstrated the use of Himar1-based transposon for random mutagenesis in A. actinomycetemcomitans. The transposition frequency was high at ×10-4 for all four strains of A. actinomycetemcomitans belonging to serotypes a, b, and c. This transposition efficiency was higher than the reported transposition frequency of Tn916 and Tn5 which is ×10-7 (Clewell and Gawron-Burke, 1986), and similar to the efficiency of Tn10 and IS903ϕkan systems. However, the Tn10 system has preference for hotspots containing six base pair symmetrical consensus sequence of 5′-GCTNAGC-3′, while the IS903 system requires host factors such as GTP for transposition (Coros et al., 2005). Himar1 transposon only requires TA dinucleotides for successful insertion. This is in contrast to other transposon systems such as Tn916 and Tn5, which require longer and more complex consensus motifs for insertion (Goryshin et al., 1998; Mullany et al., 2012). Analysis of the genome sequence of A. actinomycetemcomitans revealed that the 2.1 Mb DNA contains 1.2 × 105 TA sites which could have accounted for the high frequency of transposition obtained in this study. The transposition of Himar1 in A. actinomycetemcomitans genome was stable since all the mutants remained kanamycin resistant after at least 150 generations when serially passaged in the absence of antibiotic selection.

Even though substantial progress has been made in understanding the virulence of A. actinomycetemcomitans, it remains a challenge to study the genetics of the organism’s colonization and persistence in the oral cavity, and identify novel virulence factors due to limited genetic tools available to manipulate A. actinomycetemcomitans. So far, the recipient strains of A. actinomycetemcomitans used in transposon mutagenesis studies are limited to nalidixic acid or rifampin resistant isolates of A. actinomycetemcomitans (Kolodrubetz and Kraig, 1994; Thomson et al., 1999; Kachlany et al., 2000a; Isaza et al., 2008; Nunes et al., 2016). These strains are employed as these antibiotics are used for counter-selection during conjugation experiments with E. coli. In this work, we employed an E. coli DAP auxotroph as the donor so that counter-selection during conjugation is independent of antibiotic selection. Using this approach, we showed that Himar1 transposon mutagenesis can be achieved in four different wild-type strains of A. actinomycetemcomitans encompassing serotypes a, b, and c which are the predominant oral isolates (Dahlén et al., 2002; Yang et al., 2005; Teixeira et al., 2006) with no resistance gene markers.

Biofilm formation is an important virulence attribute of A. actinomycetemcomitans. Bacteria in biofilm exhibit an increased resistance to antibiotics and killing by host defenses compared to their planktonic counterparts (Thrower et al., 1997; Fine et al., 2001). Despite the importance of biofilm formation in the pathogenesis of A. actinomycetemcomitans, our understanding of key genes involved in the establishment of a structured bacterial community formation is still limited. Through screening of a mutant library of 16,000 transconjugants, 25 mutants were identified to be defective in biofilm formation without significant impairment in growth compared to the wild-type. We have identified one mutant with insertion in genes previously known to be associated with A. actinomycetemcomitans biofilm formation, and 21 mutants with insertions in genes which have not been reported to be involved in biofilm in A. actinomycetemcomitans but reported elsewhere to be critical in biofilm formation in other bacterial species. The genes identified in our screen include membrane proteins, structural proteins and metabolic enzymes.

The tight adherence (tad) locus comprises 14 genes (flp-1, flp-2, tadV, rcpCAB, and tadZABCDEFG) encoding factors that are essential for biofilm formation, colonization and pathogenesis in A. actinomycetemcomitans. Mutations in this gene locus cause loss of adherence, co-aggregation and formation of biofilm in A. actinomycetemcomitans (Kachlany et al., 2000b; Planet et al., 2003; Perez et al., 2006). flp-1 is the gene encoding the major structural component of Flp pilus (Inoue et al., 1998). In our screen, mutation of flp-1 resulted in significant reduction in biofilm formation in A. actinomycetemcomitans which is in consistent with the previous findings that flp-1 plays a key role in the pathogenesis of A. actinomycetemcomitans.

Our screen uncovered a mutant with disruption in putative iron transporters namely TonB-dependent receptor. We speculate that this gene is likely critical to facilitate the import of iron from the extracellular environment into the periplasmic space in A. actinomycetemcomitans. Levels of iron in the environment have been reported to regulate biofilm formation of A. actinomycetemcomitans. Under iron chelated conditions, fewer and larger aggregates form with poorly attached, weaker biofilms, compared to biofilms cultured in presence of iron (Rhodes et al., 2007; Amarasinghe et al., 2012). Several other membrane protein mutants were also discovered to be deficient in biofilm formation. These include a putative magnesium transporter and efflux pumps. Electrostatic interactions contribute to biofilm cohesion and cations such as magnesium are significant cross linkers of the biofilm matrix because they contribute to the integrity and stability of the outer membranes of the bacteria (Geesey et al., 2000). While the role of efflux pumps in biofilm formation in A. actinomycetemcomitans has not been established, efflux pumps have been shown to be important in the development of biofilm in P. aeruginosa (De Kievit et al., 2001) and E. coli (Kvist et al., 2008). In our screen, we identified two putative multidrug resistance proteins and a sodium-hydrogen antiporter to be important in biofilm. These proteins could support biofilm formation through clearing metabolic waste products and regulating intracellular pH, respectively. A transposon mutant of A. actinomycetemcomitans with insertional mutation in C39 peptidase was found to have reduced biofilm formation. This putative protein of the type I secretion family could be involved in the secretion of proteins essential in biofilm development.

Putative genes encoding several enzymes either directly involved in biofilm structure or metabolic processes were found to be involved in biofilm formation. The putative UDP-phosphate galactose phosphotransferase gene of A. actinomycetemcomitans could be functioning through affecting the production of EPS (Levander and Rådström, 2001; Dertli et al., 2013). EPS are biopolymers of microbial origin in which biofilm microorganisms are embedded. EPS determines the immediate conditions of life of biofilm cells living in this microenvironment by affecting adherence and mechanical stability (Flemming et al., 2007). The activity of pyruvate formate-lyase, an enzyme involved in synthesis of formate is increased in Staphylococcus aureus biofilm, while formate significantly increased Campylobacter jejuni’s biofilm formation under low oxygen tension (Leibig et al., 2011). Thus, formate might play a role in optimizing A. actinomycetemcomitans’s adaptation from planktonic form to biofilm. In our screen, a mutant encoding a putative ATPase was discovered to be compromised in biofilm formation. ATPases are proteins that catalyze ATP in cells and have been suggested to be responsible for stress tolerance, intracellular replication and biofilm formation in bacteria (Frees et al., 2004). The TadA protein is important in biofilm formation in A. actinomycetemcomitans and it has been proposed that the ATPase activity of this protein is required to energize the assembly or secretion of Flp pili (Bhattacharjee et al., 2001). However, future studies will be required to determine the functional role of the ATPase gene identified in our screen in biofilm formation.

Although our screen was relatively large, it is likely not saturating. Genes which have been reported to regulate surface associated proteins or biofilm structures of A. actinomycetemcomitans such as the dspB (Kaplan et al., 2003) and pgaABCD (Shanmugam et al., 2017) were not picked up in our screen. Analysis of the genome sequence revealed that there are approximately 1.2 × 105 TA sites in A. actinomycetemcomitans genome, therefore, a sample size of at least 1.2 × 105 mutants is needed to achieve a saturated mutagenesis, assuming that each mutation targets a unique site. In addition, this could have also been attributed to different bacterial strains and culture conditions employed. Interestingly, we did not pick up mutation in the same gene twice. This is an indication that Himar1 transposon likely occurred randomly in the genome of A. actinomycetemcomitans rather than having preference for specific hotspots. Although we have identified several genes associated with biofilm formation of A. actinomycetemcomitans through genome wide screening, these findings needs to be further verified through in-frame gene deletion and complementation studies as transposon insertions could potentially generate polar mutations.

 Conclusion

Our data demonstrated that the Himar1 transposon is an efficient system to generate random mutants in A. actinomycetemcomitans. This mutagenesis system allows flexibility of carrying out mutagenesis without specific requirement for recipient strains and could be employed to identify novel essential genes for survival and virulence of this periodontal pathogen.

 Author Contributions

QD performed the experiments, analyzed the data, and drafted the manuscript. KST conceived the study, analyzed the data, and wrote the manuscript. Both authors have read and approved the final manuscript.

 Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding. This study was funded by the grant R221-000-042-133 from the Ministry of Education Singapore.

We thank Yahua Chen (National University of Singapore) for helpful discussion and providing the pUTE664-oriT plasmid.

 References Amarasinghe J. J. Connell T. F. Scannapieco F. A. Haase E. M. (2012). Novel iron-regulated and Fur-regulated small regulatory RNAs in Aggregatibacter actinomycetemcomitans. Mol. Oral Microbiol. 27 327–349. 10.1111/j.2041-1014.2012.00645.x Barrett A. R. Kang Y. Inamasu K. S. Son M. S. Vukovich J. M. Hoang T. T. (2008). Genetic tools for allelic replacement in Burkholderia species. Appl. Environ. Microbiol. 74 4498–4508. 10.1128/AEM.00531-08 Bhattacharjee M. K. Kachlany S. C. Fine D. H. Figurski D. H. (2001). Nonspecific adherence and fibril biogenesis by Actinobacillus actinomycetemcomitans: TadA protein is an ATPase. J. Bacteriol. 183 5927–5936. 10.1128/JB.183.20.5927-5936.2001 Clewell D. B. Gawron-Burke C. (1986). Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu. Rev. Microbiol. 40 635–659. 10.1146/annurev.mi.40.100186.003223 Coros A. M. Twiss E. Tavakoli N. P. Derbyshire K. M. (2005). Genetic evidence that GTP is required for transposition of IS903 and Tn552 in Escherichia coli. J. Bacteriol. 187 4598–4606. 10.1128/JB.187.13.4598-4606.2005 Dahlén G. Widar F. Teanpaisan R. Papapanou P. Baelum V. Fejerskov O. (2002). Actinobacillus actinomycetemcomitans in a rural adult population in southern Thailand. Oral Microbiol. Immunol. 17 137–142. 10.1034/j.1399-302X.2002.170301.x De Kievit T. R. Parkins M. D. Gillis R. J. Srikumar R. Ceri H. Poole K. (2001). Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Annu. Rev. Microbiol. 45 1761–1770. 10.1128/AAC.45.6.1761-1770.2001 Dertli E. Colquhoun I. F. Gunning A. P. Bongaerts R. J. Le Gall G. Bonev B. B. (2013). Structure and biosynthesis of two exopolysaccharides produced by Lactobacillus johnsonii FI9785. J. Biol. Chem. 288 31938–31951. 10.1074/jbc.M113.507418 Ding Q. Quah S. Y. Tan K. S. (2016). Secreted adenosine triphosphate from Aggregatibacter actinomycetemcomitans triggers chemokine response. Mol. Oral Microbiol. 31 423–434. 10.1111/omi.12143 Fine D. H. Furgang D. Barnett M. L. (2001). Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planktonic and biofilm forms of Actinobacillus actinomycetemcomitans. J. Clin. Periodontol. 28 697–700. 10.1034/j.1600-051x.2001.028007697.x Flemming H. C. Neu T. R. Wozniak D. J. (2007). The EPS matrix: the “house of biofilm cells”. J. Bacteriol. 189 7945–7947. 10.1128/JB.00858-07 Frees D. Chastanet A. Qazi S. Sørensen K. Hill P. Msadek T. (2004). Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol. Microbiol. 54 1445–1462. 10.1111/j.1365-2958.2004.04368.x Geesey G. G. Wigglesworth-Cooksey B. Cooksey K. E. (2000). Influence of calcium and other cations on surface adhesion of bacteria and diatoms: a review. Biofouling 15 195–205. 10.1080/08927010009386310 Goryshin I. Miller J. Kil Y. Lanzov V. Reznikoff W. (1998). Tn5/IS50 target recognition. Proc. Natl. Acad. Sci. U.S.A. 95 10716–10721. 10.1073/pnas.95.18.10716 Halling S. M. Kleckner N. (1982). A symmetrical six-base-pair target site sequence determines Tn10 insertion specificity. Cell 28 155–163. 10.1016/0092-8674(82)90385-3 Haubek D. Ennibi O. Poulsen K. Vaeth M. Poulsen S. Kilian M. (2008). Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 371 237–242. 10.1016/S0140-6736(08)60135-X Inoue T. Tanimoto I. Ohta H. Kato K. Murayama Y. Fukui K. (1998). Molecular characterization of low-molecular-weight component protein, Flp, in Actinobacillus actinomycetemcomitans fimbriae. Microbiol. Immunol. 42 253–258. 10.1111/j.1348-0421.1998.tb02280.x Isaza M. P. Duncan M. S. Kaplan J. B. Kachlany S. C. (2008). Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis. Infect. Immun. 76 3561–3568. 10.1128/IAI.01687-07 Kachlany S. C. (2010). Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J. Dent. Res. 89 561–570. 10.1177/0022034510363682 Kachlany S. C. Fine D. H. Figurski D. H. (2000a). Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect. Immun. 68 6094–6100. Kachlany S. C. Planet P. F. Bhattacharjee M. K. Kollia E. Desalle R. Fine D. H. (2000b). Nonspecific adherence by Actinobacillus actinomycetemcomitans requires genes widespread in bacteria and archaea. J. Bacteriol. 182 6169–6176. Kaplan J. B. Ragunath C. Ramasubbu N. Fine D. H. (2003). Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J. Bacteriol. 185 4693–4698. 10.1128/JB.185.16.4693-4698.2003 Klein B. A. Tenorio E. L. Lazinski D. W. Camilli A. Duncan M. J. Hu L. T. (2012). Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis. BMC Genomics 13:578. 10.1186/1471-2164-13-578 Kolodrubetz D. Kraig E. (1994). Transposon Tn5 mutagenesis of Actinobacillus actinomycetemcomitans via conjugation. Oral Microbiol. Immunol. 9 290–296. 10.1111/j.1399-302X.1994.tb00073.x Kvist M. Hancock V. Klemm P. (2008). Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl. Environ. Microbiol. 74 7376–7382. 10.1128/AEM.01310-08 Lampe D. J. Grant T. E. Robertson H. M. (1998). Factors affecting transposition of the Himar1 mariner transposon in vitro. Genetics 149 179–187. Leibig M. Liebeke M. Mader D. Lalk M. Peschel A. Götz F. (2011). Pyruvate formate lyase acts as a formate supplier for metabolic processes during anaerobiosis in Staphylococcus aureus. J. Bacteriol. 193 952–962. 10.1128/JB.01161-10 Levander F. Rådström P. (2001). Requirement for phosphoglucomutase in exopolysaccharide biosynthesis in glucose- and lactose-utilizing Streptococcus thermophilus. Appl. Environ. Microbiol. 67 2734–2738. 10.1128/AEM.67.6.2734-2738.2001 Martin B. F. Derby B. M. Budzilovich G. N. Ransohoff J. (1967). Brain abscess due to Actinobacillus actinomycetemcomitans. Neurology 17 833–837. 10.1212/WNL.17.9.833 Meyer D. Fives-Taylor P. (1998). Oral pathogens: from dental plaque to cardiac disease. Curr. Opin. Microbiol. 1 88–95. 10.1016/S1369-5274(98)80147-1 Mullany P. Williams R. Langridge G. C. Turner D. J. Whalan R. Clayton C. (2012). Behavior and target site selection of conjugative transposon Tn916 in two different strains of toxigenic Clostridium difficile. Appl. Environ. Microbiol. 78 2147–2153. 10.1128/AEM.06193-11 Nilsson M. Christiansen N. Hoiby N. Twetman S. Givskov M. Tolker-Nielsen T. (2014). A mariner transposon vector adapted for mutagenesis in oral streptococci. Microbiologyopen 3 333–340. 10.1002/mbo3.171 Nunes A. C. Longo P. L. Mayer M. P. (2016). Influence of Aae autotransporter protein on adhesion and biofilm formation by Aggregatibacter actinomycetemcomitans. Braz. Dent. J. 27 255–260. 10.1590/0103-6440201600260 Perez B. A. Planet P. J. Kachlany S. C. Tomich M. Fine D. H. Figurski D. H. (2006). Genetic analysis of the requirement for flp-2, tadV, and rcpB in Actinobacillus actinomycetemcomitans biofilm formation. J. Bacteriol. 188 6361–6375. 10.1128/JB.00496-06 Planet P. J. Kachlany S. C. Fine D. H. Desalle R. Figurski D. H. (2003). The widespread colonization island of Actinobacillus actinomycetemcomitans. Nat. Genet. 34 193–198. 10.1038/ng1154 Rhodes E. R. Menke S. F. Shoemaker C. Tomaras A. P. Mcgillivary G. Actis L. A. (2007). Iron acquisition in the dental pathogen Actinobacillus actinomycetemcomitans: what does it use as a source and how does it get this essential metal? Biometals 20 365–377. Sambrook J. Fritsch E. Maniatis T. (1989). Molecular Cloning: A Laboratory Manual 2nd Edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. Shanmugam M. Oyeniyi A. O. Parthiban C. Gujjarlapudi S. K. Pier G. B. Ramasubbu N. (2017). Role of de-N-acetylase PgaB from Aggregatibacter actinomycetemcomitans in exopolysaccharide export in biofilm mode of growth. Mol. Oral Microbiol. 10.1111/omi.12188 [Epub ahead of print]. Shenker B. J. Besack D. F. Mckay T. Pankoski L. Zekavat A. Demuth D. R. (2004). Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J. Immunol. 172 410–417. 10.4049/jimmunol.172.1.410 Slots J. Reynolds H. Genco R. (1980). Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect. Immun. 29 1013–1020. Teixeira R. E. Mendes E. N. Roque de Carvalho M. A. Nicoli J. R. Farias Lde M. Magalhaes P. P. (2006). Actinobacillus actinomycetemcomitans serotype-specific genotypes and periodontal status in Brazilian subjects. Can. J. Microbiol. 52 182–188. 10.1139/W05-121 Thomson V. J. Bhattacharjee M. K. Fine D. H. Derbyshire K. M. Figurski D. H. (1999). Direct selection of IS903 transposon insertions by use of a broad-host-range vector: isolation of catalase-deficient mutants of Actinobacillus actinomycetemcomitans. J. Bacteriol. 181 7298–7307. Thrower Y. Pinney R. Wilson M. (1997). Susceptibilities of Actinobacillus actinomycetemcomitans biofilms to oral antiseptics. J. Med. Microbiol. 46 425–429. 10.1099/00222615-46-5-425 van Winkelhoff A. J. Slots J. (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol. 2000 20 122–135. 10.1111/j.1600-0757.1999.tb00160.x Withers T. R. Yin Y. Yu H. D. (2014). Identification of novel genes associated with alginate production in Pseudomonas aeruginosa using mini-himar1 mariner transposon-mediated mutagenesis. J. Vis. Exp. 85:e51346. 10.3791/51346 Yang H. Huang Y. Chan Y. Chou M. (2005). Relationship of Actinobacillus actinomycetemcomitans serotypes to periodontal condition: prevalence and proportions in subgingival plaque. Eur. J. Oral Sci. 113 28–33. 10.1111/j.1600-0722.2004.00192.x Zambon J. J. (1985). Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12 1–20. 10.1111/j.1600-051X.1985.tb01348.x Zambon J. J. Christersson L. A. Jorgen S. (1983). Actinobacillus actinomycetemcomitans in human periodontal disease. J. Periodontol. 54 707–711. 10.1902/jop.1983.54.12.707